PharmaShots | Incisive News in 3 Shots

Subscribe Now

TRAILBLAZER-ALZ 3

Eli Lilly Signs an Agreement with Banner Alzheimer's Institute to Evaluate Donanemab in P-III TRAILBLAZER-ALZ 3 Trial for Alzheimer's Disease

Eli Lilly Signs an Agreement with Banner Alzheimer's Institute to Evaluate Donanemab in P-III TRAILBLAZER-ALZ 3 Trial for Alzheime...

July 16, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us